Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* ECB dials back stimulus a notch* Airbus wins aircraft deals from Qantas and Air France-KLM* UK bank shares leap as BoE hikes rates* Euro zo...
Read moreBy Francesco Guarascio and Panu Wongcha-umBRUSSELS/BANGKOK, Dec 16 (Reuters) - Tens of millions of migrants may be denied COVID-19 vaccines from a global programme because some major manufacturers are worried about legal risks from harmful side ef...
Read more(Repeats with no changes to story text)By Francesco Guarascio and Panu Wongcha-umBRUSSELS/BANGKOK, Dec 16 (Reuters) - Tens of millions of migrants may be denied COVID-19 vaccines from a global programme because some major manufacturers are worried ...
Read more* Upbeat U.S. Federal Reserve boosts risk appetite* U.S. crude inventories drop more than expected, demand surges* Britain, S. Africa post biggest rise in daily COVID-19 cases (New throughout, updates prices, market activity and comments; new byl...
Read more
TOP NEWS: GSK, Sanofi Covid jab booster shows strong immune response
Read more(Adds details, context)PARIS, Dec 15 (Reuters) - French drugmaker Sanofi and its British partner GlaxoSmithKline said on Wednesday a single booster dose of their recombinant adjuvanted COVID-19 vaccine candidate delivered consistently strong immun...
Read more(Recasts, adds details, comments)By Benoit Van OverstraetenPARIS, Dec 15 (Reuters) - Sanofi and GlaxoSmithKline said on Wednesday they expect data from late-stage clinical trials of its booster dose of their COVID-19 vaccine candidate in the first...
Read more(Adds details throughout)By Benoit Van OverstraetenPARIS, Dec 15 (Reuters) - Sanofi and GlaxoSmithKline said on Wednesday a single booster dose of their COVID-19 vaccine candidate provided strong immune responses, preliminary data from clinical tr...
Read more(Adds details and quotes)LONDON, Dec 14 (Reuters) - The Omicron variant of the novel coronavirus is showing a higher rate of reinfection that other variants and its growth rate is shortening in the United Kingdom, the Health Security Agency's chie...
Read moreLONDON, Dec 14 (Reuters) - Infection from one variant of coronavirus should protect against severe disease from another variant, but it may not protect against mild disease or from transmission of the virus, a leading UK health official said on T...
Read moreLONDON, Dec 14 (Reuters) - The Omicron variant of the novel coronavirus is showing a higher rate of reinfection that other variants and its growth rate is shortening in the United Kingdom, the Health Security Agency's chief medical adviser said o...
Read moreBy Krishna N. DasNEW DELHI, Dec 14 (Reuters) - India is struggling to export its surplus of COVID-19 vaccines as logistical hurdles delay their use in many countries despite low levels of inoculation, vaccine producer the Serum Institute of India ...
Read more(Adds details)LONDON, Dec 14 (Reuters) - The chair of Britain's vaccine group said on Tuesday that calling an earlier and faster COVID-19 vaccine booster campaign would not necessarily have been the right policy given the scientific evidence at th...
Read moreLONDON, Dec 14 (Reuters) - The British government's scientific vaccine advisory group is discussing whether or not to advise children as young as five receive COVID vaccines, the chair of Britain's vaccine group said on Tuesday."We are discussing ...
Read moreLONDON, Dec 14 (Reuters) - The chair of Britain's vaccine group said on Tuesday that calling an earlier and faster COVID-19 vaccine booster campaign would not necessarily have been the right policy given the scientific evidence at the time.Asked i...
Read more
Last checked at